Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001839882-22-022698)

Filing Details

Accession Number:: 0001839882-22-022698
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-10-03 16:35:12
Reporting Period:: 2022-09-30

Accepted Time:: 2022-10-03 16:35:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1625101	Pulse Biosciences Inc.	PLSE	Surgical & Medical Instruments & Apparatus (3841)	465696597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1913245	Patrick Kevin Danahy	C/O Pulse Biosciences, Inc. 3957 Point Eden Way Hayward CA 94545	Chief Executive Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-09-30	6,500	$2.30	6,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This purchase price represents the weighted average purchase price of the shares purchased on September 30, 2022, ranging from $2.28 to $2.31 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.